Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 16 AL 30

Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series

James OG, Linares AR, Hellegers C, Doraiswamy PM, Wong TZ.

Clin Nucl Med. 2021 Jul 1;46(7):605-608. doi: 10.1097/RLU.0000000000003493.

Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype

Abbatemarco JR, Jones SE, Larvie M, Bekris LM, Khrestian ME, Krishnan K, Leverenz JB.

Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:1533317520981225. doi: 10.1177/1533317520981225.

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.

JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.

Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease

Leuzy A, Cullen NC, Mattsson-Carlgren N, Hansson O.

Curr Opin Neurol. 2021 Apr 1;34(2):266-274. doi: 10.1097/WCO.0000000000000904.

The complexity of Alzheimer's disease: an evolving puzzle

Ferrari C, Sorbi S.

Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21.

The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease

Xiong YL, Meng T, Luo J, Zhang H.

Eur Neurol. 2021;84(1):6-15. doi: 10.1159/000513008. Epub 2021 Jan 21.

Advances in Brain Amyloid Imaging

Krishnadas N, Villemagne VL, Doré V, Rowe CC.

Semin Nucl Med. 2021 May;51(3):241-252. doi: 10.1053/j.semnuclmed.2020.12.005. Epub 2021 Jan 19.

The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease

Altiné-Samey R, Antier D, Mavel S, Dufour-Rainfray D, Balageas AC, Beaufils E, Emond P, Foucault-Fruchard L, Chalon S.

Fundam Clin Pharmacol. 2021 Jun;35(3):582-594. doi: 10.1111/fcp.12654. Epub 2021 Mar 8.

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease

Zhang Y, Wang Y, Shi C, Shen M, Lu F.

Transl Neurodegener. 2021 Feb 1;10(1):6. doi: 10.1186/s40035-021-00230-9.

New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease

Guzman-Martinez L, Calfío C, Farias GA, Vilches C, Prieto R, Maccioni RB.

J Alzheimers Dis. 2021;82(s1):S51-S63. doi: 10.3233/JAD-201059.

Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses

Zhuang QS, Meng L, Wang Z, Shen L, Ji HF.

J Alzheimers Dis. 2021;80(1):271-281. doi: 10.3233/JAD-201235.

Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases

Campese N, Palermo G, Del Gamba C, Beatino MF, Galgani A, Belli E, Del Prete E, Della Vecchia A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F.

Expert Rev Proteomics. 2021 Jan;18(1):27-48. doi: 10.1080/14789450.2021.1886929. Epub 2021 Mar 7.

Clinical validity of increased cortical uptake of [(18)F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework

Wolters EE, Dodich A, Boccardi M, Corre J, Drzezga A, Hansson O, Nordberg A, Frisoni GB, Garibotto V, Ossenkoppele R.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2097-2109. doi: 10.1007/s00259-020-05118-w. Epub 2021 Feb 6.

Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

Rostamzadeh A, Schwegler C, Gil-Navarro S, Rosende-Roca M, Romotzky V, Ortega G, Canabate P, Moreno M, Schmitz-Luhn B, Boada M, Jessen F, Woopen C.

J Alzheimers Dis. 2021;80(2):601-617. doi: 10.3233/JAD-200484.

The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects

Chalkias E, Topouzis F, Tegos T, Tsolaki M.

J Alzheimers Dis. 2021;80(2):493-504. doi: 10.3233/JAD-201516.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias